Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Body mass index and future schizophrenia in Israeli male adolescents.

Weiser M, Knobler H, Lubin G, Nahon D, Kravitz E, Caspi A, Noy S, Knobler HY, Davidson M.

J Clin Psychiatry. 2004 Nov;65(11):1546-9.

PMID:
15554770
2.

Association between nonpsychotic psychiatric diagnoses in adolescent males and subsequent onset of schizophrenia.

Weiser M, Reichenberg A, Rabinowitz J, Kaplan Z, Mark M, Bodner E, Nahon D, Davidson M.

Arch Gen Psychiatry. 2001 Oct;58(10):959-64.

PMID:
11576035
3.

Body mass index and prevalence of obesity in a French cohort of patients with schizophrenia.

Limosin F, Gasquet I, Leguay D, Azorin JM, Rouillon F.

Acta Psychiatr Scand. 2008 Jul;118(1):19-25. doi: 10.1111/j.1600-0447.2008.01208.x.

PMID:
18582344
4.

Self-reported drug abuse in male adolescents with behavioral disturbances, and follow-up for future schizophrenia.

Weiser M, Reichenberg A, Rabinowitz J, Kaplan Z, Caspi A, Yasvizky R, Mark M, Knobler HY, Nahon D, Davidson M.

Biol Psychiatry. 2003 Sep 15;54(6):655-60.

PMID:
13129661
5.

Prevalence of obesity in adolescent and young adult patients with and without schizophrenia and in relationship to antipsychotic medication.

Theisen FM, Linden A, Geller F, Schäfer H, Martin M, Remschmidt H, Hebebrand J.

J Psychiatr Res. 2001 Nov-Dec;35(6):339-45.

PMID:
11684141
6.

Elaboration on premorbid intellectual performance in schizophrenia: premorbid intellectual decline and risk for schizophrenia.

Reichenberg A, Weiser M, Rapp MA, Rabinowitz J, Caspi A, Schmeidler J, Knobler HY, Lubin G, Nahon D, Harvey PD, Davidson M.

Arch Gen Psychiatry. 2005 Dec;62(12):1297-304.

PMID:
16330717
7.

[Bodyweight in inpatients with schizophrenia].

Wetterling T, Pest S, Müssigbrodt H, Weber B.

Psychiatr Prax. 2004 Jul;31(5):250-4. German.

PMID:
15243875
8.

Height, weight and body mass index in early adulthood and risk of schizophrenia.

Sørensen HJ, Mortensen EL, Reinisch JM, Mednick SA.

Acta Psychiatr Scand. 2006 Jul;114(1):49-54.

PMID:
16774661
9.

The distribution of body mass index among individuals with and without schizophrenia.

Allison DB, Fontaine KR, Heo M, Mentore JL, Cappelleri JC, Chandler LP, Weiden PJ, Cheskin LJ.

J Clin Psychiatry. 1999 Apr;60(4):215-20.

PMID:
10221280
10.

Schizophrenia and obesity: impact of antipsychotic medications.

Wirshing DA.

J Clin Psychiatry. 2004;65 Suppl 18:13-26. Review.

11.

Prevalence of diabetes mellitus in chronic schizophrenic inpatients in relation to long-term antipsychotic treatment.

Cohen D, Dekker JJ, Peen J, Gispen-de Wied CC.

Eur Neuropsychopharmacol. 2006 Apr;16(3):187-94. Epub 2005 Nov 2.

PMID:
16263247
12.

The prevalence of obesity and associated morbidity among 17-year-old Israeli conscripts.

Bar Dayan Y, Elishkevits K, Grotto I, Goldstein L, Goldberg A, Shvarts S, Levin A, Ohana N, Onn E, Levi Y, Bar Dayan Y.

Public Health. 2005 May;119(5):385-9.

PMID:
15780326
13.

[Schizophrenia, obesity and pharmacotherapy-associated weight gain].

Carpiniello B, Corda E, Maccioni R, Pinna F.

Clin Ter. 2008 Sep-Oct;159(5):299-306. Italian.

PMID:
18998030
14.

Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.

Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.

Clin Ther. 2008 Dec;30(12):2378-86. doi: 10.1016/j.clinthera.2008.12.020.

PMID:
19167596
15.

A 4-fold risk of metabolic syndrome in patients with schizophrenia: the Northern Finland 1966 Birth Cohort study.

Saari KM, Lindeman SM, Viilo KM, Isohanni MK, Järvelin MR, Laurén LH, Savolainen MJ, Koponen HJ.

J Clin Psychiatry. 2005 May;66(5):559-63.

PMID:
15889940
16.

Data on diabetes from the French cohort study in schizophrenia.

Philippe A, Vaiva G, Casadebaig F.

Eur Psychiatry. 2005 Dec;20 Suppl 4:S340-4.

PMID:
16459248
17.

Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme.

Poulin MJ, Chaput JP, Simard V, Vincent P, Bernier J, Gauthier Y, Lanctôt G, Saindon J, Vincent A, Gagnon S, Tremblay A.

Aust N Z J Psychiatry. 2007 Dec;41(12):980-9.

PMID:
17999270
18.

Attenuation of antipsychotic-induced weight gain with early behavioral intervention in drug-naive first-episode psychosis patients: A randomized controlled trial.

Alvarez-Jiménez M, González-Blanch C, Vázquez-Barquero JL, Pérez-Iglesias R, Martínez-García O, Pérez-Pardal T, Ramírez-Bonilla ML, Crespo-Facorro B.

J Clin Psychiatry. 2006 Aug;67(8):1253-60.

PMID:
16965204
19.

Behavioral treatment of obesity in patients taking antipsychotic medications.

Kalarchian MA, Marcus MD, Levine MD, Haas GL, Greeno CG, Weissfeld LA, Qin L.

J Clin Psychiatry. 2005 Aug;66(8):1058-63.

PMID:
16086623
20.

Body composition in psychotic disorders: a general population survey.

Saarni SE, Saarni SI, Fogelholm M, Heliövaara M, Perälä J, Suvisaari J, Lönnqvist J.

Psychol Med. 2009 May;39(5):801-10. doi: 10.1017/S0033291708004194. Epub 2008 Aug 20.

PMID:
18713488

Supplemental Content

Support Center